E. van Garderen

3.1k citations
46 papers · 2.3k indexed · h-index 23

E. van Garderen

45 papers receiving 2.2k citations

Peers

E. van Garderen
Comparison fields: 5 of 103
  • Equine 99
  • Small Animals 349
  • Immunology 513
  • Endocrinology, Diabetes and Metabolism 364
  • Pulmonary and Respiratory Medicine 577
Replace H. Gerber with:
H. Gerber Switzerland
Gerard R. Rutteman Netherlands
Renée Laufer Amorim Brazil
Oliver A. Garden United Kingdom
Clinton D. Lothrop United States
Liliana Tatarczuch Australia
Ryo Goitsuka Japan
Antonietta Salustri Italy
Valentina Zappulli Italy
M. Caniatti Italy
E. van Garderen relative to H. Gerber Switzerland H. Gerber's profile →
Citations per field
00.5×3.7×
H. Gerber · 1×
Citations per year

Countries citing papers authored by E. van Garderen

Since Specialization
Citations

This map shows the geographic impact of E. van Garderen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. van Garderen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. van Garderen more than expected).

Fields of papers citing papers by E. van Garderen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. van Garderen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. van Garderen. The network helps show where E. van Garderen may publish in the future.

Co-authorship network

The 25 scholars most cited alongside E. van Garderen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with E. van Garderen Line = papers co-authored together E. van Garderen links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20227
2 202011
3 20191
4 20151
5 2005101
6 200365
7 200231
8 200249
9 2002137
10 200214
11 200118
12 200032
13 200027
14 199915
15 199928
16 19981
17 199846
18 199514
19 1995102
20 199414

About E. van Garderen

E. van Garderen is a scholar working on Equine, Endocrinology, Diabetes and Metabolism and Small Animals, having authored 46 papers that have together received 2.3k indexed citations. Recurring topics across this work include Growth Hormone and Insulin-like Growth Factors (14 papers), Veterinary Oncology Research (13 papers), TGF-β signaling in diseases (6 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Cell Adhesion Molecules Research (4 papers), Virus-based gene therapy research (3 papers), Animal health and immunology (3 papers) and Veterinary Medicine and Surgery (3 papers). The work is most often cited by research in Equine (99 citations), Small Animals (349 citations) and Immunology (513 citations). E. van Garderen has collaborated with scholars based in Netherlands, Belgium and United Kingdom. Frequent co-authors include Gerard R. Rutteman, Jan A. Mol, Theo van Laar, Ralph Meuwissen, John Zevenhoven, Sirith Douma, Daniel S. Peeper, Marjolein van Egmond, Jack A. Schalken and Annemiek B. van Spriel. Their work appears in journals such as Veterinary Quarterly, Molecular and Cellular Endocrinology, Endocrinology, The Prostate and Apmis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026